|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.00 GBX | +1.47% |
|
+2.83% | -25.57% |
| 10:37pm | EARNINGS AND TRADING: Allergy Therapeutics names next executive chair | AN |
| 06:22pm | Forterra plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Forterra plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 627.2 | 386.2 | 364.4 | 341.2 | 390 | 279 | - | - |
| Change | - | -38.43% | -5.63% | -6.37% | 14.31% | -28.46% | - | - |
| Enterprise Value (EV) 1 | 602.8 | 410.1 | 481.8 | 447 | 465.6 | 355.1 | 340.4 | 323 |
| Change | - | -31.98% | 17.5% | -7.23% | 4.17% | -23.74% | -4.12% | -5.13% |
| P/E | 14x | 6.86x | 28.5x | 19.5x | 23.2x | 13.3x | 11.3x | 9.47x |
| PBR | 2.68x | 1.83x | 1.81x | 1.52x | 1.68x | 1.22x | 1.17x | 1.09x |
| PEG | - | 0.2x | -0.4x | 0.6x | -6.42x | 0.5x | 0.6x | 0.5x |
| Capitalization / Revenue | 1.69x | 0.85x | 1.05x | 0.99x | 1.01x | 0.77x | 0.72x | 0.68x |
| EV / Revenue | 1.63x | 0.9x | 1.39x | 1.3x | 1.21x | 0.97x | 0.88x | 0.78x |
| EV / EBITDA | 8.56x | 4.6x | 8.29x | 8.6x | 7.56x | 6.42x | 5.56x | 4.62x |
| EV / EBIT | 11.2x | 5.64x | 12.6x | 14.3x | 11.1x | 10.2x | 8.52x | 6.72x |
| EV / FCF | 17.1x | 9.13x | -10.6x | 16.9x | 8.69x | 15.8x | 11.3x | 9.23x |
| FCF Yield | 5.84% | 10.9% | -9.4% | 5.91% | 11.5% | 6.32% | 8.86% | 10.8% |
| Dividend per Share 2 | 0.099 | 0.146 | 0.044 | 0.03 | 0.062 | 0.0485 | 0.06 | 0.0738 |
| Rate of return | 3.59% | 7.82% | 2.49% | 1.85% | 3.34% | 3.57% | 4.41% | 5.43% |
| EPS 2 | 0.197 | 0.272 | 0.062 | 0.083 | 0.08 | 0.1021 | 0.1208 | 0.1437 |
| Distribution rate | 50.3% | 53.7% | 71% | 36.1% | 77.5% | 47.5% | 49.7% | 51.4% |
| Net sales 1 | 370.4 | 455.5 | 346.4 | 344.3 | 386 | 364.4 | 385.9 | 411.7 |
| EBITDA 1 | 70.4 | 89.2 | 58.1 | 52 | 61.6 | 55.29 | 61.18 | 69.89 |
| EBIT 1 | 54 | 72.7 | 38.1 | 31.2 | 42 | 34.66 | 39.96 | 48.09 |
| Net income 1 | 45.5 | 58.8 | 12.8 | 17.5 | 17 | 24.06 | 25.3 | 30.5 |
| Net Debt 1 | -24.4 | 23.9 | 117.4 | 105.8 | 75.6 | 76.04 | 61.41 | 43.96 |
| Reference price 2 | 2.760 | 1.866 | 1.768 | 1.620 | 1.854 | 1.360 | 1.360 | 1.360 |
| Nbr of stocks (in thousands) | 227,258 | 206,948 | 206,112 | 210,614 | 210,370 | 205,168 | - | - |
| Announcement Date | 10/3/22 | 9/3/23 | 26/3/24 | 12/3/25 | 11/3/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.54x | 0.95x | 6.25x | 3.86% | 371M | ||
| 31.3x | 4.96x | 16.45x | 0.74% | 36.91B | ||
| 35.66x | 3.67x | 18.81x | 0.94% | 36.44B | ||
| 30.2x | 5.45x | 16.03x | 0.6% | 34.35B | ||
| 13.2x | 1.57x | 7.22x | 2.3% | 33.74B | ||
| 18.9x | 2.5x | 9.57x | 1.28% | 27.66B | ||
| 23.5x | 6.87x | 14.91x | 1.86% | 24.07B | ||
| 82.19x | 4.48x | 84.13x | 0.32% | 22.01B | ||
| 11.85x | 1.32x | 6.5x | 0.82% | 17.74B | ||
| 37.33x | 2.37x | 14.59x | 0.48% | 11.16B | ||
| Average | 29.67x | 3.41x | 19.45x | 1.32% | 24.45B | |
| Weighted average by Cap. | 30.54x | 3.85x | 19.81x | 1.1% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- FORT Stock
- Valuation Forterra plc
Select your edition
All financial news and data tailored to specific country editions
















